Skip Navigation

Ritalin Lawsuit Claims Novartis Failed to Warn of Compulsive Behavior Linked to ADHD Drug

Ritalin Lawsuit Claims Novartis Failed to Warn of Compulsive Behavior Linked to ADHD Drug

A West Virginia woman has filed a lawsuit alleging that her use of Ritalin led to compulsive behavior, including a gambling problem that resulted in her facing embezzlement charges and losing her job.

The complaint (PDF) was brought by Christine Wilcox, her husband Phinneaus and her sister, Jennifer Wilcox McGinley, in West Virginia Circuit Court on April 16. It was removed to the U.S. District Court for the Northern District of West Virginia by the defendant, Novartis Pharmaceuticals Inc., that same day.

Wilcox alleges that she developed compulsive behaviors, including gambling and shopping, after being prescribed generic Ritalin for ADHD in 2023.

Ritalin Compulsive Behavior Side Effects

Ritalin (methylphenidate) was originally approved by the U.S. Food and Drug Administration (FDA) in 1955 as a treatment for narcolepsy and depression. It was later granted approval in 1962 for the treatment of children with attention deficit hyperactivity disorder (ADHD).

However, several studies throughout the years have linked Ritalin use to compulsive behavior, yet since the incidents have been rare, the findings have not been considered conclusive.

One study published in 2016 by Indian researchers linked Ritalin side effects to obsessive-compulsive behavior in a 14-year-old boy. The side effects appeared within 10 days of him being prescribed the medication. Once treatment was stopped, the effects faded in about two weeks.

Reviewing more scientific literature, the researchers found other similar cases, which tended to subside after one to two months of being taken off Ritalin treatment.

An estimated four million people ages 12 and older in the U.S. used Ritalin as of 2022. However, due to its use as a recreational drug, more than half a million of those report misusing it.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Ritalin Side Effects Lawsuit

According to Wilcoxโ€™s lawsuit, she was diagnosed with ADHD in January 2023. After trying several different medications, and due to a worldwide shortage of other drugs at the time, she was prescribed generic Ritalin in May 2023. At the time, she was not made aware of any of the drugโ€™s potential obsessive compulsive side effects.

Wilcox says she stopped taking Ritalin in March 2024, after realizing she had developed a problem with compulsive gambling and shopping.

โ€œAfter going to her boss, she was fired from her job for embezzlement because she used a company credit card in unauthorized manners. She had this credit card for 2 years before taking this medication with absolutely zero issues of unauthorized usage.โ€

Christine Wilcox et al v. Novartis Pharmaceuticals Inc.

She was charged with felony embezzlement in August 2024, โ€œeffectively ruining her career,โ€ the lawsuit states.

However, Wilcoxโ€™s sister, Jennifer, recognized the behavior as extremely unusual, the lawsuit indicates. Having extensive research experience, she found multiple studies linking Ritalin to compulsive behavior and informed her sister.

According to the complaint, Novartis knew or should have known about the risk of compulsive behavior for years but failed to provide adequate warnings to patients or the medical community.

Wilcox presents claims of reckless disregard, negligence and failure to warn. She is seeking both compensatory and punitive damages.

Sign up for more legal news that could affect you or your family.

Image Credit: Shutterstock.com / Aninka Bongers-Sutherland
Irvin Jackson
Written By: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

As the number of lawsuits over tabletop fire pits continues to grow, the CPSC has issued a warning indicating that despite a consumerโ€™s death linked to one product, the manufacturer has not agreed to remove the devices from the market.
A Depo-Provera meningioma lawsuit argues that Pfizer had a duty to warn women about scientific evidence linking the birth control shot to potential brain tumor growth yet failed to do so.